MyCelx Tech. Corp. - AGM Statement

Mycelx Technologies

17/09/2026 13:50

		
		
		
		
		
	
	
RNS Number : 2558V
  
MyCelx Technologies Corporation
  
17 September 2026
  
 

		

			

				17 September 2026
			
			

				 
			
			

				MYCELX Technologies Corporation
			
			

				("MYCELX" or the "Company")
			
			

				 
			
			

				AGM Statement
			
			

				 
			
			

				MYCELX Technologies Corporation (AIM: MYX), a leading provider of proprietary water treatment technology to the Oil and Gas and other industries worldwide, announces that, at the Company’s Annual Meeting (‘AGM’) to be held at 2:00 p.m. today, Tom Lamb, Chairman, will make the following statement.
			
			

				 
			
			

				"The Company stands at a key inflection point that reflects a number of years of hard work by the team. As noted in the interim results, the last 8 months have seen a massive expansion of the quality and size of the opportunity pipeline.
			
			

				 
			
			

				Key to this increased momentum has been the approval of the Company’s technology by a global integrated oil company, adding to the two existing approvals from a leading Middle Eastern producer and another global integrated oil company. This validation takes a considerable amount of time and resources but smooths the path to inclusion in future projects.
			
			

				 
			
			

				The Company has seen a 200% increase in the opportunity pipeline from January to August of this year. The pipeline includes 11 potential project awards with two US super majors and one Middle Eastern producer expected to be awarded in the next 6-12 months and worth a total of $20 million - $22 million. The timing of contract awards will dictate delivery and revenue recognition. 
			
			

				 
			
			

				While we may not win all these contracts, MYCELX is well qualified to deliver them and has built strong relationships with these high quality customers giving  the Company confidence that it is well positioned to be awarded a material proportion of them, as well as others in the broader pipeline.
			
			

				 
			
			

				The Board’s expectations for the current financial year remain unchanged, but are subject to timing of the expected award of a contract and it’s delivery by year-end.”
			
			

				 
			
			

				For further information, please contact:
			
			

				 
			
			

				

					

						

							MYCELX Technologies Corporation
						
						

							Connie Mixon, CEO
						
						

							Kim Slayton, CFO
						
						

							 
						
						

							 
						
					
					

						

							 
						
						

							Tel: +1 888 306 6843
						
					
				
				

					

						

							Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)
						
						

							Giles Balleny / Callum Davidson / Elysia Bough (Corporate Finance)
						
						

							Harriet Ward (Corporate Broking)
						
						

							Jasper Berry / Michael Johnson (Sales)
						
					
					

						

							 
						
						

							Tel: +44 20 7220 0500
						
						

							 
						
					
				
			
			

				 
			
		
	
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
AGMUBSURNOUKAAR